Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5697626 | 0.84 | GAA (0.38) | ALDH1A1ALOX15GAAL3MBTL1PKM | |
| SCHEMBL9129658 | 0.82 | MAPT (0.31) | MAPT | |
| SCHEMBL21135599 | 0.81 | ALDH1A1 (0.32) | ALDH1A1ALOX15 | |
| SCHEMBL24070062 | 0.79 | — | — | |
| SCHEMBL24070084 | 0.79 | — | — | |
| SCHEMBL18900991 | 0.76 | ALDH1A1 (0.45) | ALDH1A1ALOX15GAAL3MBTL1PKM | |
| SCHEMBL1401924 | 0.76 | ALDH1A1 (0.45) | ALDH1A1ALOX15GAAL3MBTL1PKM | |
| SCHEMBL25697065 | 0.75 | — | — | |
| SCHEMBL25697064 | 0.75 | — | — | |
| SCHEMBL25697076 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10221255-B2 | Composition for the immediate stopping of a free-radical polymerization | BASF SE (DE) | 2019-03-05 | — | — | US | disclosed |
| US-20180171035-A1 | COMPOSITION FOR THE IMMEDIATE STOPPING OF A FREE-RADICAL POLYMERIZATION | BASF SE (DE) | 2018-06-21 | — | — | US | disclosed |
| US-20180171035-A1 | COMPOSITION FOR THE IMMEDIATE STOPPING OF A FREE-RADICAL POLYMERIZATION | BASF SE (DE) | 2018-06-21 | — | — | US | disclosed |
| WO-2016202883-A1 | COMPOSITION FOR IMMEDIATELY ENDING RADICAL POLYMERIZATION | BASF SE (DE) | 2016-12-22 | — | — | WO | disclosed |
| US-8937086-B2 | Compounds for the treatment of pathologies associated with aging and degenerative disorders | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2015-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10221255-B2 | Composition for the immediate stopping of a free-radical polymerization | FASTKD5, TYK2, FASTKD1 | ALDH1A1 1387/4885ALOX15 381/4885GAA 4489/4885 |
| US-20180171035-A1 | COMPOSITION FOR THE IMMEDIATE STOPPING OF A FREE-RADICAL POLYMERIZATION | FASTKD5, TYK2, FASTKD1 | ALDH1A1 1387/4885ALOX15 381/4885GAA 4489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.